About Affinivax
Affinivax is a company based in Cambridge (United States) founded in 2013 was acquired by GSK in May 2022.. Affinivax has raised $359.49 million across 5 funding rounds from investors including BlackRock, Bain Capital and T. Rowe Price. The company has 132 employees as of December 31, 2022. Affinivax operates in a competitive market with competitors including Brii Biosciences, Insmed, Neon Therapeutics, Eligo Bioscience and Lodo Therapeutics, among others.
- Headquarter Cambridge, United States
- Employees 132 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Affinivax Inc
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Funding Insights of Affinivax
Affinivax has successfully raised a total of $359.49M across 5 strategic funding rounds. The most recent funding activity was a Series C round of $226 million completed in January 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Series C — $226.0M
-
First Round
First Round
(30 Oct 2014)
- Investors Count 15
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2021 | Amount | Series C - Affinivax | Valuation | Rock Springs Capital , Foresite Capital | |
| Apr, 2020 | Amount | Series B - Affinivax | Valuation | Viking Global Investors | |
| Dec, 2017 | Amount | Series A - Affinivax | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Affinivax
Affinivax has secured backing from 16 investors, including venture fund and institutional investors. Prominent investors backing the company include BlackRock, Bain Capital and T. Rowe Price. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage and late-stage biotech and finance companies are funded.
|
Founded Year | Domain | Location | |
|
Multi-stage investment firm invests in healthcare and life sciences companies
|
Founded Year | Domain | Location | |
|
Health-tech companies are targeted for venture capital investments.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Affinivax
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Affinivax
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Affinivax Comparisons
Competitors of Affinivax
Affinivax operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Brii Biosciences, Insmed, Neon Therapeutics, Eligo Bioscience and Lodo Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of biologics to treat hepatitis B infection
|
|
| domain | founded_year | HQ Location |
Developer of small molecule inhibitors for rare lung diseases
|
|
| domain | founded_year | HQ Location |
Tumor-specific neoantigens are identified for personalized cancer vaccine development.
|
|
| domain | founded_year | HQ Location |
In vivo gene editing technology is developed for microbiome modulation.
|
|
| domain | founded_year | HQ Location |
Developer novel therapeutics to treat resistant infectious diseases and cancers using AI
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Affinivax
Frequently Asked Questions about Affinivax
When was Affinivax founded?
Affinivax was founded in 2013 and raised its 1st funding round 1 year after it was founded.
Where is Affinivax located?
Affinivax is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Is Affinivax a funded company?
Affinivax is a funded company, having raised a total of $359.49M across 5 funding rounds to date. The company's 1st funding round was a Series A of $6.99M, raised on Oct 30, 2014.
How many employees does Affinivax have?
As of Dec 31, 2022, the latest employee count at Affinivax is 132.
What does Affinivax do?
Affinivax was established in 2013 in Cambridge, United States, within the biotechnology sector. Conjugate vaccines targeting infectious diseases are developed using the Multiple Antigen-Presenting System (MAPS) platform. Protective polysaccharides and proteins are conjugated into a single formulation through this technology. A broad immune response is elicited against pathogenic microorganisms. Operations center on advancing vaccine programs for various infectious threats.
Who are the top competitors of Affinivax?
Affinivax's top competitors include Brii Biosciences, Insmed and Osivax.
Who are Affinivax's investors?
Affinivax has 16 investors. Key investors include BlackRock, Bain Capital, T. Rowe Price, Citadel, and Gates Foundation.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.